Earnings Outlook For Verrica Pharmaceuticals

Verrica Pharmaceuticals VRCA will release its quarterly earnings report on Tuesday, 2025-05-13. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Verrica Pharmaceuticals to report an earnings per share (EPS) of $-0.15.

The announcement from Verrica Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.06, leading to a 7.56% drop in the share price the following trading session.

Here's a look at Verrica Pharmaceuticals's past performance and the resulting price change:

Market Performance of Verrica Pharmaceuticals's Stock

Shares of Verrica Pharmaceuticals were trading at $0.44 as of May 09. Over the last 52-week period, shares are down 94.64%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Verrica Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.